Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis

Clinical and Experimental Immunology

Volumn 188, Issue 2, 2017, Pages 254-262

  Aggarwal, A ^a   Gupta, R ^a   Negi, V S ^b   Rajasekhar, L ^c   Misra, R ^a   Singh, P ^d   Chaturvedi, V ^d   Sinha, S ^a,d  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^c NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^d CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

biomarkers; cyclophosphamide; glomerulonephritis; systemic lupus erythematosus

Indexed keywords

ALBUMIN; ALPHA 1 ANTICHYMOTRYPSIN; HAPTOGLOBIN; IMMUNOGLOBULIN J CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; OROSOMUCOID; RETINOL BINDING PROTEIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN URINE LEVEL; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; TWO DIMENSIONAL GEL ELECTROPHORESIS; URINE SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; LUPUS NEPHRITIS; PROCEDURES; RHEUMATOID ARTHRITIS; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TANDEM MASS SPECTROMETRY; URINE; YOUNG ADULT;

ADULT; ALPHA 1-ANTICHYMOTRYPSIN; ARTHRITIS, RHEUMATOID; BIOMARKERS; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HAPTOGLOBINS; HUMANS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; PROTEOMICS; RETINOL-BINDING PROTEINS; SEVERITY OF ILLNESS INDEX; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 85013661335     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12930     Document Type: Article

References (34)

1. Ward MM. Changes in the incidence of end-stage renal disease due to lupus nephritis in the United States, 1996–2004. J Rheumatol 2009; 36:63–7.
2. Misra R, Gupta R. Biomarkers in lupus nephritis. Int J Rheum Dis 2015; 18:219–32.
3. Soliman S, Mohan C. Lupus nephritis biomarkers. Clin Immunol 2016; doi: 10.1016/j.clim.2016.08.001.
4. Thongboonkerd V. Recent progress in urinary proteomics. Proteomics Clin Appl 2007; 1:780–91.
5. Suzuki M, Wiers K, Brooks EB et al. Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis. Pediatr Res 2009; 65:530–6.
6. Brunner HI, Bennett MR, Mina R et al. Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum 2012; 64:2687–97.
7. Zhang X, Jin M, Wu H et al. Biomarker discovery for lupus nephritis through longitudinal urine proteomics. Kidney Int 2008; 74:799–807.
8. Somparn P, Hirankarn N, Leelahavanichkul A, Khovidhunkit W, Thongboonkerd V, Avihingsanong Y. Urinary proteomics revealed prostaglandin H2D-isomerase, not Zn-α2-glycoprotein, as a biomarker for active lupus nephritis. J Proteomics 2012; 75:3240–7.
9. Varghese SA, Powell TB, Budisavljevic MN et al. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol 2007; 18:913–22.
10. Wu T, Fu Y, Brekken D et al. Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis. J Immunol 2010; 184:2183–93.
11. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725.
12. Hahn BH, McMahon MA, Wilkinson A et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res 2012; 64:797–808.
13. Mischak H, Kolch W, Aivaliotis M et al. Comprehensive human urine standards for comparability and standardization in clinical proteome analysis. Proteomics Clin Appl 2010; 4:464–78.
14. Magistroni R, Ligabue G, Lupo V et al. Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin. Nephrol Dial Transplant 2009; 24:1672–81.
15. Markwell MA, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978; 87:206–10.
16. Sinha S, Kosalai K, Arora S et al. Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. Microbiology 2005; 151:2411–9.
17. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 1996; 68:850–8.
18. Maurya VK, Singh K, Sinha S. Suppression of Eis and expression of Wag31 and GroES in Mycobacterium tuberculosis cytosol under anaerobic culture conditions. Indian J Exp Biol 2014; 52:773–80.
19. Kazemipour N, Qazizadeh H, Sepehrimanesh M, Salimi S. Biomarkers identified from serum proteomic analysis for the differential diagnosis of systemic lupus erythematosus. Lupus 2015; 24:582–7.
20. Fattahi S, Kazemipour N, Hashemi M, Sepehrimanesh M. Alpha-1 antitrypsin, retinol binding protein and keratin 10 alterations in patients with psoriasis vulgaris, a proteomic approach. Iran J Basic Med Sci 2014; 17:651–5.
21. Norden AG, Lapsley M, Unwin RJ. Urine retinol-binding protein 4: a functional biomarker of the proximal renal tubule. Adv Clin Chem 2014; 63:85–122.
22. Yeung CK, Wong KL, Ng RP, Ng WL. Tubular dysfunction in systemic lupus erythematosus. Nephron 1984; 36:84–8.
23. Sesso R, Rettori R, Nishida S, Sato E, Ajzen H, Pereira AB. Assessment of lupus nephritis activity using urinary retinol-binding protein. Nephrol Dial Transplant 1994; 9:367–71.
24. Marks SD, Shah V, Pilkington C, Woo P, Dillon MJ. Renal tubular dysfunction in children with systemic lupus erythematosus. Pediatr Nephrol 2005; 20:141–8.
25. Lim YK, Jenner A, Ali AB et al. Haptoglobin reduces renal oxidative DNA and tissue damage during phenylhydrazine-induced hemolysis. Kidney Int 2000; 58:1033–44.
26. Pavón EJ, Muñoz P, Lario A et al. Proteomic analysis of plasma from patients with systemic lupus erythematosus: increased presence of haptoglobin alpha2 polypeptide chains over the alpha1 isoforms. Proteomics 2006; S282–92.
27. D'Armiento J, Dalal SS, Chada K. Tissue, temporal and inducible expression pattern of haptoglobin in mice. Gene 1997; 195:19–27.
28. Sturfelt G, Sjöholm AG. Complement components, complement activation, and acute phase response in systemic lupus erythematosus. Int Arch Allergy Immunol 1984; 75:75–83.
29. Fleming S, Gibson AA. Proteinase inhibitors in the kidney and its tumours. Histopathology 1986; 10:1303–13.
30. Conz P, Bevilacqua PA, Ronco C et al. Alpha-1-antichymotrypsin in renal biopsies. Nephron 1990; 56:387–90.
31. Tada T, Ohkubo I, Niwa M, Sasaki M, Tateyama H, Eimoto T. Immunohistochemical localization of Zn-alpha 2-glycoprotein in normal human tissues. J Histochem Cytochem 1991; 39:1221–6.
32. Sörensen-Zender I, Bhayana S, Susnik N et al. Zinc-α2-glycoprotein exerts antifibrotic effects in kidney and heart. J Am Soc Nephrol 2015; 26:2659–68.
33. Candiano G, Musante L, Bruschi M et al. Repetitive fragmentation products of albumin and alpha-1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J Am Soc Nephrol 2006; 17:3139–48.
34. Gupta R, Yadav A, Aggarwal A. Longitudinal assessment of monocyte chemo-attractant protein-1 in lupus nephritis as a biomarker of disease activity. Clin Rheumatol 2016; 35:2707–14.